Christopher Zosh
Director of Finance/CFO at STATERA BIOPHARMA, INC.
Profile
Christopher Zosh is currently the Director at Panacela Labs, Inc. since 2017 and the VP, Chief Financial & Accounting Officer at Statera Biopharma, Inc. since 2014.
Previously, he worked at Cleveland BioLabs, Inc. as the CAO, Chief Executive & Financial Officer from 2019 to 2021.
Mr. Zosh completed his undergraduate degree at the State University of New York at Buffalo.
Christopher Zosh active positions
| Companies | Position | Start |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director of Finance/CFO | 2022-05-26 |
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Director/Board Member | 2017-06-30 |
Former positions of Christopher Zosh
| Companies | Position | End |
|---|---|---|
| STATERA BIOPHARMA, INC. | Chief Executive Officer | 2021-07-26 |
Training of Christopher Zosh
| State University of New York at Buffalo | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| STATERA BIOPHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- Christopher Zosh
